Prof. Dr. med. Eva Peters leitet seit 2010 das Psychoneuroimmunologie Labor an der Klinik für Psychosomatik der Justus-Liebig Universität in Giessen.

Sie hat sich im Fach Psychoneuroimmunologie habilitiert und ist Doppelfachärztin sowohl für Dermatologie als auch für Psychosomatik. Zusätzlich ist sie zertifizierte Psychoonkologin sowie Neurodermitis und Urtikaria Trainerin und in der Zusatzausbildung zur Systemischen Psychotherapeutin.

Sie ist Sprecherin des Arbeitskreises Psychosomatische Dermatologie (AkPsychDerm) der Deutschen Gesellschaft für Dermatologie (DDG) und Mitgründerin der Arbeitsgruppe molekulare Psychosomatik (AG MolPsych) in der Deutschen Gesellschaft für Psychosomatische Medizin (DGPM) und war über ein Jahrzehent Sprecherin des Arbeitskreises Neuroendokrinoimmunologie (AKNEI) der Deutschen Gesellschaft für Immunologie (DGFI). Sie arbeitete wissenschaftlich, didaktisch und klinisch u.a. an der Boston University, USA, der Bradford University, UK, der Universitätsklinik Hamburg Eppendorf und der Medizinischen Hochschule Brandenburg. Neben Humanmedizin studierte sie Philosophie, Politik und Theaterwissenschaften an der FU und HU Berlin und war Mitglied der Interdisziplinären Arbeitsgruppe „Übung am Phantom“, die Ausstellungen, Seminare und Filmreihen zu Genderthemen u.a. in den Kunstwerken Berlin durchführte.

In Wissenschaft, Lehre und klinische Aktivität fokussiert Prof. Peters seit Abschluss des „Arzt im Praktikum“ und Approbation als Ärztin 2001 auf Stress und Stressfolgen für körperliche und seelische Gesundheit. Ihre interdisziplinären Erkenntnisse bringt sie u.a. in die Leitlinienentwicklung der AWMF als Initiatorin der S3-Leitlinienentwicklung „Psychosomatische Dermatologie“ ein, sowie als Mitautorin der Leitlinien für „Long-/Post-COVID“, „Neurodermitis“, „Prävention von Allergie und Asthma“ sowie „Trans-Gesundheit“. Seit 1997 hat sie mit Stand Ende 2024 85 Originalarbeiten, 56 Übersichtsarbeiten und Kongressberichte sowie zahlreiche Buchbeiträge in einschlägigen Lehrbüchern wie „Psychosomatik: Neurobiologisch fundiert und evidenzbasiert, ein Lehr- und Handbuch“ und „Uexküll, Psychosomatische Medizin“ verfasst. Ihr kumulativer Gesamt-Impact-Faktor liegt laut ISI Web of Knowledge mit Stand Ende 2024 bei 529.7 Impact Punkten und sie hat laut Google Scholar einen Hirsch-Index von 59.

Fachärztin für Dermatologie und Venerologie

Fachärztin für Psychosomatische Medizin und Psychotherapie mit tiefenpsychologischer Ausrichtung

2025:

Peters EMJ. Kapitel 6: Psychoneuroendokrinologie (Psychoneuroendocrinology). In: Uexküll, Psychosomatische Medizin (Uexküll, psychosomatic medicine). Kruse J, Langewitz W, Schneider A, Söllner W, Waller C, Weidner K, Zipfel S (eds); Elsevier, Amsterdam, 9. Edition. 2024.

Peters EMJ. Kapitel 93: Dermatologie (Dermatology). In: Uexküll, Psychosomatische Medizin (Uexküll, psychosomatic medicine). Kruse J, Langewitz W, Schneider A, Söllner W, Waller C, Weidner K, Zipfel S (eds); Elsevier, Amsterdam, 9. Edition. 2024.

Peters EMJ. Ein Neurodermitisfall – biopsychosozial aufgeklärt (A case of atopic dermatitis—the biopsychosocial view). Die Dermatologie 76: 76-80. 2025. DOI: 10.1007/s00105-024-05465-x. Impact factor (2023): 0.8

Kruse J, Peters EMJ. Kapitel 4: Biologische Grundlagen der Anpassung und ihre Entwicklung: eine Einführung (The biology of adaptation and it´s development). In: Uexküll, Psychosomatische Medizin (Uexküll, psychosomatic medicine). Kruse J, Langewitz W, Schneider A, Söllner W, Waller C, Weidner K, Zipfel S (eds); Elsevier, Amsterdam, 9. Edition. 2024.

Huthsteiner K, Finke JB, Peters EMJ, Kleinke K, Klucken T, Stalder T. What is the best sampling region for endocrine hair analysis? A comparison between the posterior vertex and occipital region and recommendation for standardization. Psychoneuroendocrinology in print. 2025. Impact factor (2023): 3.4

Wintermann GB, Abraham S, Peters EMJ, Beissert S, Weidner K. Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis. Sci Rep 15 (1): 1553, 2025. DOI: 10.1038/s41598-024-84794-2. Impact factor (2023): 3.8

Heinzmann S, Etzler S, Hartmann A, Klein EM, Herpertz S, Pape M, Heinzmann S, Doering S, Hofmann T, Rose M, Imbierowicz K, Geiser F, Bierling A, Weidner K, Rademacher J, Michalek S, Morawa E, Erim Y, Skoda EM, Teufel M, Peters EMJ, Kruse J, von Boetticher D, Herrmann-Lingen C, Noehre M, de Zwaan M, Dinger U, Friederich HC, Niecke A, Albus C, Zwerenz R, Beutel M, Roenneberg C, Henningsen P, Stein B, Waller C, Hake K, Spitzer C, Stengel A, Zipfel S, Weimer K, Gündel H, Kessler H, Spieler D, Lahmann C, Zeeck A. Personality functioning in inpatients with eating disorders: association with symptom severity and treatment outcome. Eur Eat Disord Rev. 2025. DOI: 10.1002/erv.3183. Impact factor (2023): 3.9

2024:

Peters EMJ: Gastbeitrag: Immunologische Erkenntnisse beim Post-COVID-Syndrom. In: Post-COVID erfolgreich therapieren. Kupferschmitt A, Köllner (eds); Urban & Fischer Verlag, Elsevier GmbH, München, 2024.
Peters EMJ: Immunologische Aspekte und Stressregulation bei Fatigue. Bundesgesundheitsblatt 67(11): 1222-1230. 2024. DOI: 10.1007/s00103-024-03952-z. Impact factor (2023): 1.7

Peters EMJ, Nicolas Rohleder. Kapitel 7: Psychoimmunologie. In: Psychosomatik: Neurobiologisch fundiert und evidenzbasiert, ein Lehr- und Handbuch. Egle U, Heim C, Strauß B, von Känel R (eds); Kohlhammer, Stuttgart, 2. Ausgabe, 2024.

Peters EMJ, Gieler U. Kapitel 37.1: Bio-psycho-soziale Zusammenhänge bei dermatologischen Erkrankungen. In: Psychosomatik: Neurobiologisch fundiert und evidenzbasiert, ein Lehr- und Handbuch. Egle U, Heim C, Strauß B, von Känel R (eds); Kohlhammer, Stuttgart, 2. Ausgabe, 2024.

Rommel FR, Tumala S, Urban AL, Siebenhaar F, Kruse J, Gieler U, Peters EMJ. Stress Affects Mast Cell Proteases in Murine Skin in a Model of Atopic Dermatitis-like Allergic Inflammation. Int J Mol Sci: 25(11). 2024. DOI: 10.3390/ijms25115738. Impact factor (2022): 5.6

Böhm M, Sommer R, Gieler U, Staubach P, Zink A, Apfelbacher C, Peters EMJ. Krankheit Vitiligo - Ein Positionspapier zur Stigmatisierung, Einschränkung der Lebensqualität und psychosozialen Komorbidität. J Dtsch Dermatol Ges (JDDG): DOI: 10.1111/ddg.15503. Impact factor (2022): 3.9

Gieler U, Peters EMJ. Kapitel 37.2: Psychodermatologische Erkrankungen. In: Psychosomatik: Neurobiologisch fundiert und evidenzbasiert, ein Lehr- und Handbuch. Egle U, Heim C, Strauß B, von Känel R (eds); Kohlhammer, Stuttgart, 2. Ausgabe, 2024.

Gogoll C, Peters EMJ, Köllner V, Koczulla R. S1 Leitlinie Long/Post-COVID-Syndrom. Die Urologie: 63(11): 1158–1161. 2024. DOI: 10.1007/s00120-024-02373-9. Impact factor (2022): 0.6

Wintermann, GB, Bierling AL, Peters EMJ, Abraham S, Beissert S, Weidner, K. Psychosocial stress affects the change of mental distress under dermatological treatment – a prospective cohort study in patients with psoriasis. Stress and Health: 1-13. 2023. DOI: 10.1002/smi.326. Impact factor (2023): 3.1

Bierling A, Doering S, Weidner K, Pape M, Kessler H, Hofmann T, Rose M, Imbierowicz K, Geiser F, Rademacher J, Michalek S, Morawa E, Erim Y, Schneider J, Teufel M, Hartmann A, Lahmann C, Peters EMJ, Kruse J, von Boetticher D, Herrmann-Lingen C, Nöhr M, de Zwaan M, Dinger U, Friederich HC, Niecke A, Albus C, Zwerenz R, Beutel M, Sattel HC, Henningsen P, Stein B, Waller C, Hake K, Spitze C, Stengel A, Zipfel S, Weimer K, Gündel H, Herpertz S, Croy I. The interplay of personality pathology and treatment outcome in psychosomatic psychotherapy: A longitudinal analysis using latent change score modelling. Comp Psych: 135(4):152532. 2024. DOI: 10.1016/j.comppsych.2024.152532. Impact factor (2023): 4.3

Datye S, Smiljanic M, Shetti RH, MacRae-Miller A, van Teijlingen E, Latha Vinayakarao L, Peters EMJ, Lebel CA, Tomfohr-Madsen L, Giesbrecht G, Khashu M, Conrad ML. Prenatal maternal mental health and resilience in the United Kingdom during the SARS-CoV-2 Pandemic: A cross-national comparison. Front Psychiatry: 15, 1411761. 2024. DOI: 10.3389/fpsyt.2024.1411761. Impact factor (2023): 3.2

Werfel T, Heratizadeh A, Aberer W, Augustin M, Biedermann T, Bauer A, Fölster-Holst R, Kahle J, Kinberger M, Nemat K, Neustädter I, Peters EMJ, von Kiedrowski R, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Simon D, Spindler T, Traidl-Hoffmann C, Werner RN, Wollenberg A, Worm M, Ott H. S3 guideline Atopic dermatitis: Part 1 - Part 1 - General aspects, topical and non-drug therapies, special patient groups. J Dtsch Dermatol Ges (JDDG): 22(1):137-153. 2024. DOI: 10.1111/ddg.15230. Impact factor (2022): 3.9

Werfel T, Heratizadeh A, Aberer W, Augustin M, Biedermann T, Bauer A, Fölster-Holst R, Kahle J, Kinberger M, Nemat K, Neustädter I, Peters EMJ, von Kiedrowski R, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Simon D, Spindler T, Traidl-Hoffmann C, Werner RN, Wollenberg A, Worm M, Ott H. S3-Leitlinie Atopische Dermatitis: Teil 2 - Systemische Therapie (S3 guideline Atopic dermatitis: Part 2 - Systemic treatment (S3 guideline Atopic dermatitis: Part 2 - Systemic treatment). J Dtsch Dermatol Ges (JDDG): 22(2):307-322. 2024. DOI: 10.1111/ddg.15229_g. Online ahead of print. Impact factor (2022): 3.9

Koczulla AR, Ankermann T, Behrends U, Berlit P, Brinkmann F, Frank U, Glöckl R, Gogoll C, Häuser W, Hohberger B, Huber G, Hummel T Köllner V, Krause S,, Kronsbein J, Maibaum T, Otto-Thöne A, Pecks U, Peters EMJ, Peters S, Pfeifer M, Platz T, Pletz M, Powitz F, Rabe KF, Scheibenbogen C, Schneider D, Stallmach A, Stegbauer M, Töpfner N,von Versen-Höynck F, Wagner HO, Waller C, Widmann CN, Wienbergen H, Winterholler C, Wirtz H, Zwick R: AWMF S1-Leitlinie Long/Post-COVID (Stand 05.03.2023). AWMF Register Nr. 020/027I. https://register.awmf.org/assets/guidelines/020-027l_S1_Long-Post-Covid_2023-11.pdf

Gogoll C, Ankermann T, Behrends U, Berlit P, Brinkmann F, Häuser W, Huber G, Hummel T, Hohberger B, Koczulla AR, Köllner V, Leventic M, Maibaum T, Mooren FC, Peters EMJ, Peters S, Platz T, Pletz M, Pongratz G, Powitz F, Rabe KF, Rehmet L, Reißhauer A, Scheibenbogen C, Schieffer E, Schilling C, Simon P, Stallmach A, Stegbauer M, Thöne-Otto A, Töpfner, Wagner HO, Widmann CN, Winterholler C, Wirtz H, Wienbergen A.  Leitlinie “Long/Post-COVID-Syndrom" für Betroffene, Angehörige, nahestehende und pflegende Personen. AWMF Register Nr. 020 – 027. https://register.awmf.org/assets/guidelines/020-027p_S1_Post_COVID_Long_COVID_2024-09.pdf   

2023:

Peters, EMJ, Gieler, U: Allergieprävention und psychosoziale Faktoren (Alternate title: Allergy prevention and psychosocial factors).  Prävention und Rehabilitation: 35(1):  30-38. 2023. DOI:10.5414/ALX022932023

Peters EMJ. Stress und Haut: Was sollten Hautärztinnen und Hautärzte wissen? Hautnah Dermatologie: 39(1): 20-24. 2023

Peters EMJ. Immunologische Aspekte von Long COVID. Psychotherapie im Dialog (PiD): 24: 51-55. 2023. DOI: 10.1055/a-1935-6413

Peters EMJ, Stierle C. Psychodermatologie: Grundlagen für den Aufbruch zu neuen Versorgungsformen. [Psychodermatology: Foundations for new developments in integrated care]. Aktuelle Dermatologie: 49: 358-372. 2022. CME Fortbildung. DOI: 10.1055/a-2093-6375

Pauli-Pott U, Cosana A, Schloß S, Skoluda N, Nater U, Tumala S, Kruse J, Peters EMJ. Hair brain-derived neurotrophic factor (BDNF) as predictor of developing psychopathological symptoms in childhood. J Affect Dis: 320:428-435. 2023. Impact factor (2023): 4.9

Gogoll C, Peters EMJ, Köllner V, Koczulla R. S1 Leitlinie: Long-/Post COVID Syndrom. Pflege: 76(6): 30-33. 2023. Impact factor (2023): 0.8

Botschek T, Hußlein V, Peters EMJ, Brosig B. Hair cortisol as outcome parameter for psychological and neuropsychiatric interventions-a literature review. Front Psychiatry: 14:1227153. 2023. DOI: 10.3389/fpsyt.2023.1227153. Impact factor (2023): 3.2    

Gogoll C, Peters EMJ, Köllner V, Koczulla AR. Nach der Pandemie. Heilberufe: 75(7-8):35-37. 2023. DOI: 10.1007/s00058-023-3112-1.

Schepko M, Stumpf KC, Tumala S, Peters EMJ, Kupfer J, Schut C. Study protocol: Neuro-inflammatory parameters as mediators of the relationship between social anxiety and itch intensity: a cross-sectional, controlled laboratory study in patients with psoriasis and healthy skin controls. PLoS ONE 18(3): e02819892023. 2023. DOI: 10.1371/journal.pone.0281989. Impact factor (2023): 2.9

Doering S, Herpertz S, Hofmann T, Rose M, Imbierowicz K, Geiser F, Croy I, Weidner K, Rademacher J, Michalek S, Morawa E, Erim Y, Teigelack P, Teufel M, Hartmann A, Lahmann C, Peters EMJ, Kruse J, von Boetticher D, Herrmann-Lingen C, Nöhre M, de Zwaan M, Dinger U, Friederich HC, Niecke A, Albus C, Zwerenz R, Beutel M, Roenneberg C, Henningsen P, Stein B, Waller C, Hake K, Spitzer C, Stengel A, Zipfel S, Weimer K, Guendel H, Kessler H. What kind of patients receive inpatient and day-hospital treatment in departments of psychosomatic medicine and psychotherapy in Germany? Psychother Psychosom: 92(1):49-54. 2023. DOI:10.1159/000527881. Impact Factor (2023): 16.3
Doering S, Herpertz S, Pape M, Hofmann T, Rose M, Imbierowicz K, Geiser F, Bierling A, Weidner K, Rademacher J, Michalek S, Morawa E, Erim Y, Teigelack P, Teufel M, Hartmann A, Lahmann C, Peters EMJ, Kruse J, von Boetticher D, Herrmann-Lingen C, Nöhre M, de Zwaan M, Dinger U, Friederich HC, Niecke A, Albus C, Zwerenz R, Beutel M, Sattel HC, Henningsen P, Stein B, Waller C, Hake K, Spitzer C, Stengel A, Zipfel S, Weimer K, Guendel H, Kessler H. The Multicenter Effectiveness Study of Inpatient and Day Hospital Treatment in Departments of Psychosomatic Medicine and Psychotherapy in Germany (MEPP). Front Psychiatry: 7:14:1155582. 2023. DOI: 10.3389/fpsyt.2023.1155582. Impact Factor (2023): 3.2

Gogoll C, Ankermann T, Behrends U, Berlit P, Brinkmann F, Huber G, Hummel T, Hohberger B, Kamp A, Koczulla AR, Krause S, Leventic M, Maibaum T, Peters EMJ, Peters S, Platz T, Pletz M, Pongratz G, Powitz F, Rabe KF, Reißhauer A, Scheibenbogen C, Stallmach A, Stegbauer M, Thöne-Otto A, Töpfner N, Wagner HO, Widmann CN, Winterholler C, Wirtz H, Wienbergen H. Eine Leitlinie “Long/Post-COVID-Syndrom" für Betroffene, Angehörige, nahestehende und pflegende Personen, die sich auf eine ärztliche Leitlinie stützt („S1-Leitlinie Long-/Post-COVID“ (2. Auflage, Stand 01/2023). AWMF Register Nr. 020/027. 2023 https://register.awmf.org/assets guidelines/020-027p_S1_Post_COVID_Long_COVID_2023-02.pdf

2022:

O’Sullivan JDB*, Peters EMJ*, Amer Y, Atuluru P, Chéret J, Rosenberg A, Picard M, Paus R, *=equal contribution. The impact of perceived stress on the hair follicle: Towards solving a psychoneuroendocrine and neuroimmunological puzzle. Front Neuroendocrinol: 66: 101008. 2022. DOI: 10.1016/j.yfrne.2022.101008. *equally contributing. Impact Factor (2021): 8.333

 

Peters EMJ, Stierle C. Psychodermatologie: Grundlagen für den Aufbruch zu neuen Versorgungsformen. [Psychodermatology: Foundations for new developments in integrated care]. Psychother Psychosom Med Psychol: 72(3-04):155-168. 2022. DOI: 10.1055/a-1740-9408

 

Rummel C, Del Rey A, Bähr L, Krüger K, Peters EMJ: 1st European Psychoneuroimmunology Network (EPN) Autumn School: Lung-Brain Axis in Health and Disease. Neuroimmunomodulation: 29(Suppl 2): 3-8. 2022 DOI: 10.1159/000526565 

 

Basso L, Boecking B, Neff P, Brueggemann P, Mazurek B, Peters EMJ. Psychological treatment effects unrelated to hair-cortisol and hair-BDNF Levels in chronic tinnitus. Front Psychiatry: 13: 764368. 2022. Impact Factor (2021): 5.435

 

Pauli-Pott U, Cosana A, Schloß S, Skoluda N, Nater U, Tumala S, Kruse J, Peters EMJ. Hair brain-derived neurotrophic factor (BDNF) as predictor of developing psychopathological symptoms in childhood. J Affect Dis: 320:428-435. 2023. Impact factor (2021): 6.533

 

Basso L, Boecking B, Neff P, Brueggemann P, Peters EMJ, Mazurek B. Hair‑cortisol and hair‑BDNF as biomarkers of tinnitus loudness and distress in chronic tinnitus. Sci Rep 12 (1): 12: 1934. 2022. DOI: 10.1038/s41598-022-04811-0. Impact factor (2021): 4.379

 

Tretter F, Peters EMJ, Sturmberg J, Bennett J, Voit E, Dietrich JW, Smith G, Weckwerth W, Grossman Z, Wolkenhauer O, Marcum JA. Perspectives of (/memorandum for) systems thinking on COVID-19 pandemic and pathology. J Eval Clin Pract. 2022. DOI: 10.1111/jep.13772 

 

Wintermann GB, Bierling AL, Peters EMJ, Abraham S, Beissert S, Weidner K. Childhood trauma and psychosocial stress affect treatment outcome in patients with psoriasis starting a new treatment episode. Front Psychiatry: 13: 848708. 2022. Impact Factor (2021): 5.435

 

Kopp MV, Muche-Borowski C, Abou-Dakn M, Ahrens B, Beyer K, Blümchen K, Bubel P, Chaker A, Cremer M, Ensenauer R, Gerstlauer M, Gieler U, Hübner IM, Horak F, Klimek L, Koletzko BV, Koletzko S, Lau S, Lob-Corzilius T, Nemat K, Peters EMJ, Pizzulli A, Reese I, Rolinck-Werninghaus C, Rouw E, Schaub B, Schmidt S, Steiß JO, Striegel AK, Szépfalusi Z, Schlembach D, Spindler T, Taube C, Trendelenburg V, Treudler R, Umpfenbach U, Vogelberg C, Wagenmann M, Weißenborn A, Werfel T, Worm M, Sitter H, Hamelmann E. S3 guideline Allergy Prevention. Allergol Select: 6:61-97. 2022. DOI: 10.5414/ALX02303E

 

Kopp MV, Muche-Borowski C, Abou-Dakn M, Ahrens B, Beyer K, Blümchen K, Bubel P, Chaker A, Cremer M, Ensenauer R, Gerstlauer M, Gieler U, Hübner IM, Horak F, Klimek L, Koletzko BV, Koletzko S, Lau S, Lob-Corzilius T, Nemat K, Peters EMJ, Pizzulli A, Reese I, Rolinck-Werninghaus C, Rouw E, Schaub B, Schmidt S, Steiß JO, Striegel AK, Szépfalusi Z, Schlembach D, Spindler T, Taube C, Trendelenburg V, Treudler R, Umpfenbach U, Vogelberg C, Wagenmann M, Weißenborn A, Werfel T, Worm M, Sitter H, Hamelmann E.  S3-Leitlinie Allergieprävention* Allergologie: 45(3):153-194. 2022. DOI: 10.5414/ALX02303E

2021:

Peters EMJ, Schedlowski M, Watzl C, Gimsa U. To stress or not to stress: which neuroendocrine signals can mobilize the immune system against SARS-CoV-2?. Neurobiol Stress: 14: 100296. 2021. DOI: 10.1016/j.ynstr.2021.100296. Impact factor: 5.441

Peters EMJ, Schedlowski M, Watzl C, Gimsa U. Stress und Covid-19: Ein narrativer Review über neuroendokrin-immune Mechanismen, die eine Abwehr von SARS-CoV-2 verbessern könnten. Psychother Psychosom Med Psychol: 71(2):61-71. 2021. DOI: 10.1055/a-1322-3205. Impact factor (2020): 1.430

Ertle CM, Rommel FR, Tumala S, Moriwaki Y, Klein J, Kruse J, Kummer W, Gieler U, Peters EMJ. New pathways for the skin´s stress response: the cholinergic neuropeptide SLURP-1 can activate mast cells and alter cytokine production in mice. Front Immunol: 12: 631881. 2021. DOI: 10.3389/fimmu.2021.631881. 2021. Impact factor: 7.561

Passeron T, Zouboulis CC, Tan J, Andersen ML, Katta R, Lyu X, Aguilar L, Kerob D, Morita A, Krutmann J, Peters EMJ: Adult skin acute stress responses to short-term environmental and internal aggression from exposome factors. J Eur Acad Dermatol Venereol. DOI: 10.1111/jdv.17432. 2021. Impact factor: 6.166.

Koczulla AR, Glöckl R, Peters EMJ, Rabe KF, Stallmach A, Gogoll C: Long-/Post- COVID: Wenn das Virus Spuren hinterlässt. Deutsches Ärzteblatt 118 (39): A1762-A1768. 2021. Impact factor: 5.594. 

Koczulla AR, Ankermann T, Behrends U, Berlit P, Böing S, Brinkmann F, Franke C, Glöckl R, Gogoll C, Hummel T, Kronsbein J, Maibaum T, Peters EMJ, Pfeifer M, Platz T, Pletz M, Pongratz G, Powitz F, Rabe KF, Scheibenbogen C, Stallmach A, Stegbauer M, Wagner HO, Waller C, Wirtz H, Zeiher A, Zwick RH: S1-Leitlinie Post-COVID/Long-COVID. Pneumologie 75(11):869-900. DOI: 10.1055/a-1551-9734. 2021. Impact factor: 0.282

Koczulla AR, Ankermann T, Behrends U, Berlit P, Böing S, Brinkmann F, Franke C, Glöckl R, Gogoll C, Hummel T, Kronsbein J, Maibaum T, Peters EMJ, Pfeifer M, Platz T, Pletz M, Pongratz G, Powitz F, Rabe KF, Scheibenbogen C, Stallmach A, Stegbauer M, Wagner HO, Waller C, Wirtz H, Zeiher A, Zwick R: S1-Leitlinie Post-COVID/Long-COVID. AWMF Register Nr. 020/027. https://www.awmf.org/uploads/tx_szleitlinien/020-027l_S1_Post_COVID_Long_COVID_2021-07.pdf 

Werfel T, Heratizadeh A, Aberer W, Ahrens F, Augustin  M, Biedermann T, Diepgen T, Fölster-Holst R, Kahle J, Kapp A, Nemat K, Peters E, Schlaeger M, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Staab D, Traidl-Hoffmann C, Werner R, Wollenberg A, Worm M, Ott H: Update “Systemic treatment of atopic dermatitis” of the S2k-guideline on atopic dermatitis (Aktualisierung„ Systemtherapie bei Neurodermitis“ zur S2k-Leitlinie Neurodermitis). JDDG: 19(1):151-168. DOI: 10.1111/ddg.14371. 2021. Impact factor: 5.584 

2020:

Schut C, Magerl M, Hawro T, Kupfer J, Rose M, Gieler U, Maurer M, Peters EMJ. Disease activity and stress are linked in a subpopulation of chronic spontaneous urticaria patients. Allergy. 75 (1): 224-226. 2020. DOI: 10.1111/all.14015.

Peters EMJ, Neusetzer M, Akinci S, Murat A, Diekmeier S, Rose M, Leweke F, Leichsenring F, Conrad M, Kruse J. Multimodal psychotherapeutic inpatient therapy of depression is successful in patients with high cytokine production. Front Psychiatry: 11: 571636. 2020. DOI: 10.3389/fpsyt.2020.571636.

Peters EMJ, Gieler U. Kapitel 35: Dermatologische Erkrankungen. In: Psychosomatik: Neurobiologisch fundiert und evidenzbasiert, ein Lehr- und Handbuch. Egle U, Heim C, Strauß B, von Känel R (eds); Kohlhammer, Stuttgart, 1. Ausgabe, 2020.

Peters EMJ. Wie die Haut den Stress reguliert - Lehren für Klinik und Praxis aus der psychoneuroimmunologischen Untersuchung eines Beispielorgans. In: Das Unsichtbare hinter dem Sichtbaren. Gesundheit und Krankheit neu denken. Perspektiven der Psychoneuroimmunologie. Schubert C, Singer M (eds). Books on Demand, Norderstedt. 2020. ISBN: 978-3-75269-072-9

Wuertz-Kozak K, Roszkowskie M, Cambria E, Block A, Kuhn GA, Abele T, Hitzl W, Drießlein D, Müller R, Rapp MA, Mansuy IM, Peters EMJ, Wippert PM. Effects of early life stress on bone homeostasis in mice and humans. Int J Mol Sci: 21 (18): 6634. 2020. DOI: 10.3390/ijms21186634.

Gieler U, Gieler T, Peters EMJ, Linder D. Skin and Psychosomatics – Psychodermatology today / Haut und Psychosomatik – Psychodermatologie heute. JDDG: 1280-1300. 2020. DOI: 10.1111/ddg.14328_g.

Leichsenring F, Steinert C, Beutel ME, Feix L, Gündel H, Hermann A, Karabatsiakis A, Knaevelsrud C, König HH, Kolassa IT, Kruse J, Niemeyer H, Nöske F, Palmer S, Peters E, Reese JP, Reuss A, Salzer S, Schade-Brittinger C, Schuster P, Stark R, Weidner K, von Wietersheim J, Witthöft M, Wöller W, Hoyer J. Trauma-focused psychodynamic therapy and STAIR Narrative Therapy of post-traumatic stress disorder related to childhood maltreatment: trial protocol of a multicentre randomised controlled trial assessing psychological, neurobiological and health economic outcomes (ENHANCE). BMJ Open 10(12): e040123. 2020. DOI: 10.1136/bmjopen-2020-040123.

Lemmens S, Nelissen S, Dooley D, Geurts N, Peters EMJ, Hendrix S. Stress pathway modulation is detrimental or ineffective for functional recovery after spinal cord injury in mice. J Neurotraum: DOI: 10.1089/neu.2018.6211. 2020. 

 

2019:

Campiche R, Daniltchenko M, Imfeld D, Peters EMJ. Effects of the selective TrkA agonist gambogic amide on pigmentation and growth of human hair follicles in vitro. PLoS One. 14 (8): e0221757. 2019. doi: 10.1371/journal.pone.022175

 

Liffler P, Peters EMJ, Gieler U. Gibt es Hinweise auf Eigenschaften der “Sensory processing sensitivity” (SPS) bei atopisch veranlagten Persönlichkeiten? Eine Untersuchung an Eltern neurodermitis-kranker Kinder in stationärer Behandlung (Are there indications of "sensory processing sensitivity" (SPS) in atopically predisposed persons? - An examination of parents of children with atopic dermatitis in inpatient treatment). Z Psychosom Med Psychother. 65 (1): 14-26. 2019. doi: 10.13109/zptm.2019.65.1.14.

2018:

Lemmens S, Nelissen S, Dooley D, Geurts N, Peters EMJ, Hendrix S. Stress Pathway Modulation is Detrimental or Ineffective for Functional Recovery after Spinal Cord Injury in Mice. J Neurotraum: doi: 10.1089/neu.2018.6211.

Schneider-Burrus S, Jost A, Peters EMJ, Witte-Haendel E, Sterry W, Sabat R. Association of Hidradenitis Suppurativa With Body Image. JAMA Dermatol. 2018. doi: 10.1001/jamadermatol.2017.6058.

 

Jelenik T, Dille M, Müller-Lühlhoff S, Kabra DG, Zhou Z, Binsch C, Hartwig S, Lehr S, Chadt A, Peters EMJ, Kruse J, Roden M, Al-Hasani H, Castañeda TR. FGF21 regulates insulin sensitivity following long-term chronic stress. Mol Metab. 2018. doi: 10.1016/j.molmet.2018.06.012.

 

 

2017:

Assessment of Brain Derived Neurotrophic Factor in hair to study stress responses: a pilot investigation.

Harb H, González-de-la-Vara M, Thalheimer L, Klein U, Renz H, Rose M, Kruse J, Potaczek DP, Peters EMJ. Psychoneuroendocrinology, 2017 Dec; 86:134-143. doi: 10.1016/j.psyneuen.2017.09.007. Epub 2017 Sep 8.. 2017

 

Hair and stress: A pilot study of hair and cytokine balance alteration in healthy young women under major exam stress.

Peters EMJ, Müller Y, Snaga W, Fliege H, Reißhauer A, Schmidt-Rose T, Max H, Schweiger D, Rose M, Kruse J.
PLoS One. 2017 Apr 19;12(4):e0175904. doi: 10.1371/journal.pone.0175904.. eCollection 2017.

 

2016:

Shadows of beauty – prevalence of body dysmorphic concerns in Germany is increasing: data from two representative samples from 2002 and 2013.

Gieler T, Shmutzer G, Braehler E, Schut C, Peters EMJ, Kupfer J.
Acta Derm Venereol. 2016 Jun 9. doi: 10.2340/00015555-2375.
Impact factor: 3.638, Rang 8/61 (Q1) in Dermatology

 

Biologische Grundlagen der Anpassung und ihre Entwicklung: eine Einführung.
Kruse J, Peters EMJ.

In: Uexküll, Psychosomatische Medizin
Adler RH, Herzog W, Joraschky P, Köhle K, Langewitz W, Söllner W, Wesiack W (eds); Elsevier, Amsterdam, 2016

 

Peters EMJ (2016): Stressed skin? a molecular psychosomatic update on stress-causes and effects in dermatologic diseases. J Dtsch Dermatol Ges 14(3): 233-252. doi: 10.1111/ddg.12957

 

2015:

Gieler U, Gieler T, Peters EMJ, Niemeier V, Schut C (2015): Haut und Psychosomatik – Psychodermatologie heute. Ärztliche Psychotherapie 10: 142-150

 

Gieler U, Gieler T, Schut C, Niemeier V, Peters EMJ, Kupfer J (2015): Quality of Life and Comorbidities in Urticaria: What Is Known? Curr Derm Rep 4: 77-82

 

Gruber R, Börnchen C, Rose K, Daubmann A, Volksdorf T, Wladykowski E, Vidal-Y-Sy S, Peters EMJ, Danso M, Bouwstra JA, Hennies HC, Moll I, Schmuth M, Brandner JM (2015): Diverse Regulation of Claudin-1 and Claudin-4 in Atopic Dermatitis. Am J Pathol 185(10): 2777-2789

 

Niemeier V, Peters EMJ, Gieler U (2015): Skin-picking disorder. Hautarzt 66(10): 781-792

 

Nolte S, van der Mei SH, Strehl-Schwarz K, Köster J, Bender A, Rose M, Kruse J, Peters EMJ (2015): Comparison of patient-reported need of psycho-oncologic support and the doctor’s perspective: how do they relate to disease severity in melanoma patients? Psychooncology Dec 3. doi: 10.1002/pon.4050 [Epub ahead of print]

 

Rommel FR, Raghavan B, Paddenberg R, Kummer W, Tumala S, Lochnit G, Gieler U, Peters EMJ (2015): Suitability of nicotinic acetylcholine receptor α7 and muscarinic acetylcholine receptor 3 antibodies for immune detection: evaluation in murine skin. J Histochem Cytochem 63(5): 329-339

 

Sandler H, Fendel U, Peters EMJ, Rose M, Bösel R, Klapp BF (2015): Subjective experience of relaxation – induced by vibroacoustic stimulation by a Body Monochord or CD music – a randomised, controlled study in patients with psychosomatic disorders. Nordic Journal of Music Therapy. doi: 10.1080/08098131.2015.1089312

 

2014:

Peters EMJ, Sabat R, Philipp S, Helleiner E, Kruse J, Sterry W. (2014): Neuroimmunological links in dermatology: psoriasis as a model disease in stress research. Expert Review of Dermatology 7(4)

 

Peters EMJ, Mitschenko AV, Kupfer J, Kummer W, Wiegand S, Niemeier V, Potekaev N, Lvov A, Gieler U (2014): Mental Stress in Atopic Dermatitis – Neuronal plasticity and the cholinergic system are affected in atopic dermatitis and in response to acute experimental mental stress in a randomized controlled pilot study. PLoS One doi:10.1371/journal.pone.0113552

 

Pierre F, Barrientos G, Tirado-González I, Cohen M, Moschansky P, Peters EMJ, Klapp BF, Rose M, Tometten M, Blois SM (2014): Balanced levels of nerve growth factor are required for normal pregnancy progression. Reproduction 148(2): 179-189

 

2013:

Boato F, Rosenberger K, Nelissen S, Geboes L, Peters EMJ, Nitsch R, Hendrix S. (2013): Absence of IL-1beta positively affects neurological outcome, lesion development and axonal plasticity after spinal cord injury. J Neuroinflam 10(1):6. doi: 10.1186/1742-2094-10-6

 

Frank P, Barrientos G, Tirado-González I, Cohen M, Moschansky P, Peters EMJ, Klapp BF, Rose M, Tometten M, Blois SM. Pregnancy maintenance relies on a balanced expression of nerve growth factor at the fetal-maternal interface' has been successfully submitted online and is presently being given full consideration for publication in Reproduction. Reproduction (submitted)

 

Kurek A, Peters EMJ, Sabat R, Sterry W, Schneider-Burrus S. Depression is a frequent co-morbidity in patients with acne inversa (2013). J Dtsch Dermatol Ges: Epub ahead of print . doi: 10.1111/ddg.12067

 

Liezmann C, Klapp BF, Blois SM, Kruse J, Peters EMJ. Stress attenuates splenic TH-2 bias in a mouse-model of atopic dermatitis-like. PLOS ONE (submitted)

 

Peters EMJ, Liezmann C, Spatz K, Ungethüm U, Kuban RJ, Daniltchenko M, Kruse J, Imfeld D, Klapp BF, Campiche R (2013): Profiling mRNA of the Graying Human Hair Follicle Consti-tutes a Promising State-of-the-Art Tool to Assess its Aging: An Exemplary Report. Journal of Investigative Dermatology 133: 1150-1160

 

Peters EMJ, Gieler U (2013): Stress und Haut – welche Rolle spielen neuroimmunologische Zusammenhänge in der Psychosomatik dermatologischer Erkrankungen? Ärztliche Psycho-therapie und Psychosomatik 8: 75-83

 

Peters EMJ, Liezmann C, Spatz K, Ungethüm U, Kuban RJ, Daniltchenko M, Kruse J, Imfeld D, Klapp BF, Gräub R. (2013): Profiling mRNA of the graying human hair follicle constitutes a promising state of the art tool to assess its aging. J Invest Dermatol 133(5): 1150-60. doi: 10.1038/jid.2012.462

 

Peters EMJ (2013): Stress und molekulare Psychosomatik (stress and molecular psychoso-matics). Der Hautarzt 6: 402-409

 

Peters EMJ, Michenko AV, Kupfer J, Kummer W, Wiegand S, Niemeier V, Potekaev N, Lvov A, Gieler U. Neuro-immune interaction in atopic dermatitis: new roles for the non-neuronal cholinergic system in inflammation and stress. Psychoneuroendocrinology (submitted)

 

Peters EMJ, Müller Y, Snaga W, Fliege H, Reisshauer A, Schmidt-Rose T, Max H, Schwei-ger D, Kruse J, Klapp BF. Acutely perceived stress during exam affects cellular immunity and tissue regeneration in healthy young women. Brain Behav Immun (submitted)

 

2012:

Kurek A, Peters EMJ, Chanwangpong A, Sabat R, Sterry W, Schneider-Burus S (2012): Pro-found disturbances of sexual health in patients with acne inversa. J Am Acad Dermatol 67(3): 422-428

 

Peters EMJ (2012): Psychological support of skin cancer patients. Brit J Dermatol 167(2): 105-110

 

Peters EMJ, Sabat R, Philipp S, Helleiner E, Kruse J, Sterry W (2012): Neuroimmunological links in dermatology: psoriasis as a model disease in stress research. Expert Review of Dermatology 7(4): 367-375

 

Peters EMJ, Liezmann C, Klapp BF, Kruse J (2012): The neuroimmunce connection inter-feres with tissue regeneration and chronic inflammatory disease in the skin. Annals of the New York Academy of Sciences 1262(1): 118-126

 

2011:

Boato F, Hechler D, Rosenberger K, Luedecke D, Peters EM, Nitsch R, Hendrix S (2011): Interleukin-1 beta and neurotrophin-3 synergistically promote neurite growth in vitro. Journal of Neuroinflammation 8: 183

 

Krohn M, Listing M, Tjahjono G, Reisshauer A, Peters EMJ, Klapp BF, Rauchfuss M (2011): Depression, mood, stress and Th1/h2 immune balance in primary breast cancer patients undergoing classical massage therapy. Support Care Cancer 9, 1303-1311.

 

Liezmann C, Klapp B, Peters EM (2011): Stress, atopy and allergy: A re-evaluation from a psychoneuroimmunologic perspective. Dermatoendocrinol 3(1): 37-40

 

Pavlovic S, Liezmann C, Blois SM, Joachim R, Kruse J, Romani N, Klapp BF, Peters EMJ (2011): Substance P is a Key Mediator of Stress-Induced Protection from Allergic Sensitiza-tion via Modified Antigen Presentation. The Journal of Immunology 186: 848-855

 

Peters EM, Imfeld D, Gräub R (2011): Graying of the human hair follicle. J Cosmet Sci 62(2): 121-5

 

Peters EMJ, Liezmann C, Spatz K, Daniltchenko M, Joachim R, Gimenez-Rivera A, Hendrix S, Botchkarev V, Brandner JM, Klapp BF (2011): Dissecting the role of nerve growth factor in allergic inflammation: Nerve growth factor partially recovers inflamed skin from stress-induced worsening. J Invest Dermatol 131: 735-743.

 

2010:

Peters EMJ, Liezmann C, Spatz K, Daniltchenko M, Joachim R, Gimenez-Rivera A, Hendrix S, Botchkarev V, Brandner JM, Klapp BF. Dissecting the role of nerve growth factor in allergic inflammation: Nerve growth factor partially recovers inflamed skin from stress-induced worsening. J Invest Dermatol. 2010 Nov 18. (Epub ahead of print). Impact factor: 5.543

 

Peters EMJ. Oxidative Stress associated melanocyte-loss and hair growth capacity in the aging hair follicle: A model for tissue specific aging. In: Aging Hair. Trueb RM and Tobin D (eds); Springer, Heidelberg, Dordrecht, London, New York: 91-100, 2010.

 

Peters EMJ. Psychodermatology (Psychodermatologie). In: Clinical Companions Dermatology (Checkliste Dermatologie). Sterry W, Paus R (eds), Thieme, Stuttgart, 2010

 

Krohn M, Listing M, Tjahjono G, Reisshauer A, Peters EMJ, Klapp BF, Rauchfuss M. Depression, mood, stress, and Th1/Th2 immune balance in primary breast cancer patients undergoing classical massage therapy. Support Care Cancer. 2010 (Epub ahead of print). Impact factor: 2.089

 

Listing M, Krohn M, Liezmann C, Kim I, Reisshauer A, Peters EMJ, Klapp BF, Rauchfuss M. The efficacy of classical massage on stress perception and cortisol following primary treatment of breast cancer. Arch Womens Ment Health 13(2):165-73. 2010, Impact factor: 2.208

 

Listing M, Krohn M, Liezmann C, Kim I, Reisshauer A, Peters EMJ, Klapp BF, Rauchfuss M. The efficacy of classical massage on stress perception and cortisol following primary treatment of breast cancer. Arch Womens Ment Health 13(2):165-73. 2010, Impact factor: 2.208

 

Listing M, Krohn M, Liezmann C, Kim I, Reisshauer A, Peters EMJ, Klapp BF, Rauchfuss M. The efficacy of classical massage on stress perception and cortisol following primary treatment of breast cancer. Arch Womens Ment Health 13(2):165-73. 2010, Impact factor: 2.208

 

Sharov AA, Schroeder M, Sharova TY, Mardaryev AN, Peters EM, Tobin DJ, Botchkarev VA. Matrix Metalloproteinase-9 Is Involved in the Regulation of Hair Canal Formation. J Invest Dermatol. 2010 Sep 30. (Epub ahead of print). Impact factor: 5.543

 

Pavlovic S, Liezmann C, Blois SM, Joachim R, Kruse J, Romani N, Klapp BF, Peters EMJ. Substance P is a key mediator of stress-induced protection from allergic sensitization via modified antigen presentation1. J Immunol. 2010 (in print). Impact factor: 5.646

 

2009:

Peters EMJ, Tobin D. Neurobiology of Hair. In: Neuroimmunology of the Skin: Basic Science to Clinical Relevance. Granstein RD and Luger T (eds); Springer, Berlin, Heidelberg: 139-158. 2009

 

Peters EMJ, Fischer T. 8th Annual Meeting of the German Dermato-Endocrinology Working Group. J Dtsch Dermatol Ges 7(11): 924-925. 2009

 

Plonka PM, Passeron T, Brenner M, Tobin DJ, Shibahara S, Thomas A, Slominski A, Kadekaro AL, Hershkovitz D, Peters EMJ, Nordlund JJ, Abdel-Malek Z, Takeda K, Paus R, Ortonne JP, Hearing VJ, Schallreuter KU. "What are melanocytes really doing all day long…?" Exp Derm 18(9): 799-819. 2009. Impact factor: 3.259

 

Fischer TW, Peters EM. 8th Annual Meeting of the German Dermatoendocrinology Working Group (ADE) of Arbeitsgemeinschaft Dermatologische Forschung (ADF), 4.3.2009, Heidelberg. Exp Dermatol 18(12): 1082-4. 2009. Impact factor: 3.259

 

2008:

Peters EMJ, Kurzen J. Following up on Dermato-Endocrinology: the skin strives for acknowledgement as a neuro-endocrine organ. J Dtsch Dermatol Ges 12(5): 1155-1156. 2008

 

Peters EMJ, Peker B, Hendrix S. Skin and hair follicle innervation in experimental models: a review and guide for the exact and reproducible evaluation of neuronal plasticity. Exp Derm 17: 214–228. 2008. Impact factor: 3.259

 

Peters EMJ, Botchkarev V. Neuroimmunology of the hair follicle. In: Hair Growth and Disorders. Blume-Peytavi U, Tosti A, Whiting DA, Trüeb RM (eds); Springer-Verlag, Berlin, Heidelberg, New York, Barcelona, Hong Kong, London, Milan, Paris, Tokyo: 79-86. 2008

 

Siebenhaar F, Magerl M, Peters EMJ, Hendrix S, Metz M, Maurer M. Mast cell-driven skin inflammation is impaired in the absence of sensory nerves. J Allergy Clin Immunol 121(4):955-61. 2008. Impact factor: 9.773

 

Joachim RA, Noga O, Sagach V, Hanf G, Fliege H, Kocalevent RD, Peters EMJ, Klapp BF. Correlation between immune and neuronal parameters and stress perception in allergic asthmatics. Clin Exp Allergy 38(2):283-290. 2008. Impact factor: 3.556

 

Pavlovic S, Daniltchenko M, Tobin DJ, Hagen E, Klapp BF, Arck PC, Peters EMJ. Further exploring the brain-skin connection: Stress worsens dermatitis via Substance P-dependent neurogenic inflammation in mice. J Invest Dermatol 128(2):434-46. 2008. Impact factor: 5.543

 

Klapp BF, Peters EMJ. Stress and disease, or „which stress and how much of it make sick? “ (Stress und Krankheiten, oder „welcher Stress und wieviel Stress macht krank?“). Ärzteblatt, Local Medical Association Sachsen-Anhalt, Germany: 2008

 

2007:

Peters EMJ, Raap U, Welker P, Tanaka A, Matsuda H, Pavlovic-Masnicosa S, Hendrix S, Pincelli C, Paus R. Neurotrophins act as neuroendocrine regulators of skin homeostasis in health and disease. Horm Metab Res 39(2): 110-124. 2007. Impact factor: 2.715

 

Hendrix S, Peters EMJ. Neuronal plasticity and neuroregeneration in the skin: The role of inflammation. J Neuroimmunol 184(1-2): 113-126. 2007. Impact factor: 3.159

 

Peters EMJ, Liotiri S, Bodó E, Hagen E, Bíró T, Arck PC, Paus R. Probing the effects of stress mediators on the human hair follicle: Substance P holds central position. Am J Pathol 171(6):1872-86. 2007. Impact factor: 5.697

 

Siebenhaar, F, Sharov AA, Peters EMJ, Sharova TY, Syska W, Mardaryev AN, Freyschmidt-Paul P, Sundberg JP, Maurer M, Botchkarev VA. Substance P as immunomodulatory neuropeptide in a mouse model autoimmune hair loss (alopecia areata). J Invest Dermatol 127(6):1489-1497. 2007. Impact factor: 5.543

 

Spencer JD, Gibbons NC, Rokos H, Peters EMJ, Wood JM, Schallreuter KU. Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo. J Invest Dermatol 127(2): 411-420. 2007. Impact factor: 5.543

 

Joachim RA, Kuhlmei A, Dinh QT, Handjiski B, Fischer T, Peters EMJ, Klapp BF, Paus R, Arck PC. Neuronal plasticity of the "brain-skin connection": stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. J Mol Med 85(12):1369-1378. 2007. Impact factor: 4.370

 

2006:

Peters EMJ, Arck PC, Paus R. Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control. Exp Dermatol 15(1): 1-16. 2006. Impact factor: 3.259

 

Peters EMJ, Ericson ME, Hosoi J, Seiffert K, Hordinsky MK, Ansel JC, Paus R, Scholzen TE. Neuropeptidergic controls in cutaneous biology: Physiological and clinical significance. J Invest Dermatol 126(9): 1937-1947. 2006. Impact factor: 5.543

 

Peters EMJ, Hansen MG, Liezman C, Overall RW, Nakamura M, Hagen E, Klapp BF, Arck PC, Paus P. p75 neurotrophin receptor-mediated signaling promotes human hair follicle regression (catagen). Am J Pathol 168(1): 221-234. 2006. Impact factor: 5.697

 

Peters EMJ, Hendrix S, Gölz G, Klapp BF, Arck PC, Paus R. Nerve growth factor and its precursor regulate hair cycle progression in mice. J Histochem Cytochem 54(3): 275-88. 2006. Impact factor: 2.823

 

Botchkarev VA, Yaar M, Peters EMJ, Raychaudhuri SP, Botchkareva NV, Marconi A, Raychaudhuri SP, Paus R, Pincelli C. Neurotrophins in skin biology and pathology. J Invest Dermatol 126(8): 1719-1727. 2006. Impact factor: 5.543

 

Arck PC, Slominski A, Theoharides TC, Peters EMJ, Paus R. Neuroimmunology of stress: Skin takes center stage. J Invest Dermatol 126(8): 1697-1704. 2006. Impact factor: 5.543

 

Hendrix S, Warnke K, Siebenhaar F, Peters EMJ, Nitsch R, Maurer M. The majority of brain mast cells in B10.PL mice is present in the hippocampal formation. Neurosci Lett 392(3): 174-7. 2006. Impact factor: 2.200

 

Orsal AS, Blois S, Labuz D, Peters EMJ, Schaefer M, Arck PC. The Progesterone derivative dydrogesterone down-regulates Neurokinin 1 receptor expression on lymphocytes, induces a Th2 skew and exerts hypoalgesic effects in mice. J Mol Med 84(2):159-167. 2006. Impact factor: 4.370

 

Arck PC, Overall R, Spatz K, Liezman C, Handjiski B, Klapp BF, Birch-Machin MA, Peters EMJ. Towards a `free radical theory of graying´: melanocyte apoptosis in the aging human hair follicle is an indicator of oxidative stress induced tissue damage. FASEB J 20(9): 1567-1569. 2006. Impact factor: 7.049

 

2005:

Peters EMJ, Hansen MG, Overall R, Nakamura M, Pertile P, Arck P, Klapp BF, Paus R. Control of human hair growth by neurotrophins: Brain derived neurotrophic factor inhibits hair shaft elongation, induces catagen and stimulates follicular TGFï¢2 expression. J Invest Dermatol 124(4): 675-685. 2005. Impact factor: 5.543

 

Peters EMJ, Kuhlmei A, Tobin DJ, Müller-Röver S, Klapp BF, Arck PC. Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin. Brain Behav Immun 19(3): 252-262. 2005. Impact factor: 4.909

 

Sundberg JP, Peters EMJ, Paus R. Analysis of hair follicles in mutant laboratory mice. J Invest Dermatol Symp Proc 10(3): 264-270. 2005. Impact factor: 1.576

 

Hendrix S, Handjiski B, Peters EMJ, Paus R. A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamid induced alopecia in mice. Invest Dermatol 125(1): 42-51. 2005. Impact factor: 5.251

 

Arck PC, Handjiski B, Kuhlmei A, Peters EMJ, Knackstedt M, Peter A, Hunt SP, Klapp BF, Paus R. Mast cell deficient and neurokinin-1 knockout mice are protected from stress-induced hair growth inhibition. J Mol Med 83(5): 386-396. 2005. Impact factor: 4.370

 

2004:

Peters EMJ, Handjiski B, Kuhlmei A, Hagen E, Bielas H, Braun A, Klapp BF, Paus R, Arck PC. Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol 165(1): 259-71. 2004. Impact factor: 5.697

 

Magerl M, Paus R, Farjo N, Müller-Röver S, Peters EMJ, Foitzik K, Tobin DJ. Limitations of human occipital scalp hair follicle organ culture for studying the effects of minoxidil as a hair growth enhancer. Exp Dermatol 13(10): 635-42. 2004. Impact factor: 3.259

 

Tometten M, Klapp BF, Joachim R, Fest S, Zenclussen AC, Peters EMJ, Hertwig K, Arck PC. Nerve Growth Factor and its Functional Receptor TrkA are Up-regulated in Murine Decidual Tissue of Stress-triggered and Substance P-mediated Abortion. Am J Reprod Immunol (51): 86-93. 2004. Impact factor: 2.172

 

Botchkarev VA, Botchkareva NV, Peters EMJ, Paus R. Epithelial growth control by neurotrophins: leads and lessons from the hair follicle. In: NGF and related molecules in health and disease. Aloe L, Calza L (eds); ELSEVIER, Amsterdam: Prog Brain Res 146(31): 493-513. 2004

 

2003:

Peters EMJ, Botchkarev VA, Moll I, Arck P, Paus R. Neurobiology of the Murine Pelage Hair Follicle. in: The Merkel cell – structure – development – function – and Merkel cell carcinoma. Baumann KI, Halata Z, Moll I (eds); Springer-Verlag, Berlin, Heidelberg, New York, Barcelona, Hong Kong, London, Milan, Paris, Tokyo: 79-86. 2003

 

Peters EMJ, Botchkarev VA, Paus R. Neurotrophins act as regulators of hair follicle morphogenesis and cycling. in: Hair Science and Technology. Van Neste D (ed); Skinterface, Tournai-Belgium: 353-366. 2003

 

Peters EMJ, Tobin DJ, Maurer M, Overall R, Arck PC, Botchkarev VA, Paus R. The migration of melanoblasts into the developing hair follicle is accompanied by transient c-Kit-expression in melanocytes as well as keratinocytes indicating distinct roles in controls of hair pigmentation and hair growth. in: Hair Science and Technology. Van Neste D (ed); Skinterface, Tournai-Belgium: 343-351. 2003

 

Peters EMJ, Maurer M, Botchkarev VA, deMasey Jensen K, Welker P, Scott GA, Paus R. Kit is expressed by epithelial cells in vivo. J Invest Dermatol 121(5): 976-84. 2003. Impact factor: 5.543

 

Marles LK, Peters EMJ, Tobin DJ, Hibberts NA, Schallreuter KU. Tyrosine hydroxylase isoenzyme I is present in human melanosomes: a possible novel function in pigmentation. Exp Dermatol 12: 61-70. 2003. Impact factor: 3.259

 

Arck PC, Handjiski B, Peters EMJ, Klapp BF, Paus R. Topical minoxidil counteracts stress-induced hair growth inhibition in mice. Exp Dermatol 12(5): 580-90. 2003. Impact factor: 3.259

 

Arck PC, Handjiski B, Peters EMJ, Peter AS, Hagen E, Fischer A, Klapp BF, Paus R. Stress Inhibits Hair Growth in Mice by Induction of Premature Catagen Development and Deleterious Perifollicular Inflammatory Events via Neuropeptide Substance P-Dependent Pathways. Am J Pathol 162: 803-14. 2003. Impact factor: 5.697

 

Schallreuter KU, Behrens-Williams S, Khaliq TP, Picksley SM, Peters EMJ, Marles LK, Westerhof W, Miehe B, Fanghanel J. Increased epidermal functioning wild-type p53 expression in vitiligo. Exp Dermatol 12: 268-277. 2003. Impact factor: 3.259

 

2002:

Peters EMJ, Botchkarev VA, Müller-Röver S, Moll I, Rice FL, Paus R. Developmental timing of hair follicle and dorsal skin innervation in mice. J Comp Neurol 448(1): 28-52. 2002. Impact factor: 3.743

 

Peters EMJ, Tobin DJ, Botchkareva N, Maurer M, Paus R. Migration of Melanoblasts into the Developing Murine Hair Follicle Is Accompanied by Transient c-Kit-expression. J Histochem Cytochem 50(6): 751-766. 2002. Impact factor: 2.823

 

2001:

Peters EMJ, Botchkarev VA, Botchkareva NV, Paus R. Hair Cycle-Associated Remodeling of the Peptidergic Innervation of Murine Skin, and Hair Growth-Modulation by Neuropeptides. J Invest Dermatol 116(2): 236-245. 2001. Impact factor: 5.543

 

Peters EMJ, Foitzik K, Paus R, Ray S, Holick M. A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrp receptor agonists and antagonists. J Invest Dermatol 117(2): 173-178. 2001. Impact factor: 5.543

 

Schallreuter KU, Moore J, Wood JM, Beazley WD, Peters EMJ, Marles LK, Behrens-Williams SC, Dummer R, Blau N, Thöny B. Epidermal H2O2 accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes? J Invest Dermatol 116(1): 167-174. 2001. Impact factor: 5.543

 

2000:

Peters, EMJ, Tobin DA, Seidah NS, Schallreuter KU. POMC-related peptides, prohormone convertases 1 and 2 and the regulatory peptide 7B2 are present in melanosomes of human melanocytes. J Invest Dermatol 114(3):430-437. 2000. Impact factor: 5.543

 

Behrens S, Peters EMJ, Schallreuter KU. In vivo delayed-type hypersensitivity in 109 patients with vitiligo. Int J Dermatol 39: 593-598. 2000. Impact actor: 1.409

 

Tobin DJ, Peters EMJ, Schallreuter KU. Pigment Disorders of the Hair and Nails. in: Atlas of Hair and Nails. Hordinsky MK, Sawaya ME, Scher RK (eds.); Churchill Lungstone, Philadelphia, PA, USA: 157-170. 2000

 

Swanson NN, Pittelkow MR, Peters EMJ, Schallreuter KU. Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol 191: 407-416. 2000. Impact factor: 5.121

 

Müller-Röver S, Rossiter H, Paus R, Handjiski B, Peters EMJ, Murphy JE, Magerl M, Teuerkauf L, Kupper TS. Overexpression of bcl-2 protects from UVB-induced apoptosis, but promotes hair follicle regression and chemotherapy-induced alopecia. Am J Pathol 56: 1395-405. 2000. Impact factor: 5.697

 

Mecklenburg L, Tobin DJ, Müller-Röver S, Handjiski B, Wendt G, Peters EMJ, Pohl S, Moll I, Paus R. Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol 114: 909-16. 2000. Impact factor: 5.543

 

1999:

Peters, EMJ, Maurer M, Botchkarev VA, Paus R. Hair growth modulation by adrenergic drugs. Exp Dermatol 8(4): 274-281. 1999. Impact factor: 3.259

 

Botchkarev VA, Peters EMJ, Maurer M, Paus R. Hair Cycle-Dependent Changes in Adrenergic Skin Innervation and Hair Growth-Modulation by Adrenergic Drugs. J Invest Dermatol 113(6): 878-887. 1999. Impact factor: 5.543

Müller-Röver S, Rossiter H, Lindner G, Peters EMJ, Kupper TS, Paus R. Hair follicle apoptosis and Bcl-2. J Invest Dermatol Symp Proc 4(3). 272-277. 1999. Impact factor: 1.576

 

1998:

 

Maurer M, Peters EM, Botchkarev VA, Paus R. Intact hair follicle innervation is not essential for anagen induction and development. Arch Dermatol Res 290: 574-578. 1998. Impact factor: 3.4021

 

Müller-Röver S, Peters EJM, Botchkarev VA, Panteleyev A, Paus R. Distinct patterns of NCAM expression are associated with defined stages of murine hair follicle morphogenesis and regression. J Histochem Cytochem 46: 1401-1409. 1998. Impact factor: 2.823

 

Botchkarev VA, Eichmüller S, Peters EM, Pietsch P, Johansson O, Maurer M, Paus R. A simple immunofluorescence technique for simultaneous visualization of mast cells and nerve fibers reveals selectivity and hair cycle-dependent changes in mast cell--nerve fiber contacts in murine skin. Arch Dermatol Res 289: 292-302. 1998. Impact factor: 1.927

 

Botchkarev VA, Botchkareva NV, Lommatzsch M, Peters EM, Lewin GR, Subramaniam A, Braun A, Renz H, Paus R. BDNF overexpression induces differential increases among subsets of sympathetic innervation in murine back skin. Eur J Neurosci 10: 3276-3283. 1998. Impact factor: 3.385

 

Botchkarev VA, Welker P, Albers KM, Botchkareva NV, Metz M, Lewin GR, Bulfone-Paus S, Peters EM, Lindner G, Paus R. A new role for neurotrophin-3: involvement in the regulation of hair follicle regression (catagen). Am J Pathol 153: 785-799. 1998. Impact factor: 5.697

 

1997:

 

Paus R, Peters EMJ, Eichmüller S, Botchkarev VA. Neural mechanisms of hair growth control. J Invest Dermatol Symp Proc 2: 61-8. 1997. Impact factor: 1.576